Overview

Genpathway products and services have wide utility in the discovery and development of targeted drugs, novel diagnostic biomarkers, and the identification of causal disease and pharmacological pathways.

We offer a suite of genome-wide ChIP products for understanding gene regulation and genetic pathways—FactorPath™for discovery of transcription factor binding sites; TranscriptionPath™ for discovery of genomic DNA sequences undergoing active transcription within cells; MethylPath™ and HistonePath™ for discovery and analysis of epigenetic events such as DNA methylation and histone modification; and Bisulfite Sequencing for determining the locations and methylation status of cytosines.

Genpathway also provides services for discovery of novel biomarkers that have the potential to enable more accurate prediction and assessment of disease, prediction of drug response, and treatment selection for individual patients.

In addition, we offer customized assay development and specific services to optimize ChIP-based procedures, including antibody qualification, preparation of ChIP-ready materials and samples, and amplification and library generation of ChIP samples.